Palvella Therapeutics (PVLA) Asset Utilization Ratio (2014 - 2024)

Palvella Therapeutics (PVLA) has 11 years of Asset Utilization Ratio data on file, last reported at 0.69 in Q3 2024.

• Asset Utilization Ratio for Q3 2024 came in at 0.69, up 33.17% year-over-year; the trailing twelve-month figure through Sep 2024 was 0.69 (up 33.17% YoY), and the FY2021 annual result was 0.22, down 9.31% from the prior year.
• Asset Utilization Ratio eased to 0.69 in Q3 2024 per PVLA's latest filing, from 1.31 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 2.03 in Q1 2024 and troughed at 0.13 in Q3 2021.
• A 5-year average of 0.43 and a median of 0.26 in 2021 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio sank 57.47% in 2021, then jumped 983.92% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.27 in 2020, then tumbled by 44.83% to 0.15 in 2021, then rose by 25.78% to 0.18 in 2022, then surged by 179.23% to 0.51 in 2023, then soared by 33.17% to 0.69 in 2024.
• Business Quant data shows PVLA's Asset Utilization Ratio at 0.69 in Q3 2024, 1.31 in Q2 2024, and 2.03 in Q1 2024.